Aminosalicylates, thiopurines and methotrexate in inflammatory bowel disease: Is it possible to discontinue the treatment?

被引：3

作者：

Sedano Munoz, Rocio ^{[1
]}

Quera Pino, Rodrigo ^{[2
]}

Ibanez Lazo, Patricio ^{[2
]}

Figueroa Corona, Carolina ^{[2
]}

Flores Perez, Lilian ^{[2
]}

机构：

[1] Univ Chile, Hosp Clin, Serv Gastroenterol, Santiago, Chile

[2] Clin Las Condes, Serv Gastroenterol, Programa Enfermedad Inflamatoria Intestinal, Santiago, Chile

来源：

GASTROENTEROLOGIA Y HEPATOLOGIA | 2019年 / 42卷 / 05期

关键词：

Inflammatory bowel disease; Mesalazine; Thiopurines; Azathioprine; Mercaptopurine; Methotrexate; Biological therapy withdrawal; RANDOMIZED CONTROLLED-TRIAL; ACTIVE RECTAL INFLAMMATION; ULCERATIVE-COLITIS; FECAL CALPROTECTIN; CROHNS-DISEASE; LONG-TERM; MAINTENANCE TREATMENT; DOUBLE-BLIND; RISK-FACTORS; HISTOLOGICAL REMISSION;

D O I：

10.1016/j.gastrohep.2019.01.013

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The current goals of treatment in inflammatory bowel disease, both Crohn's disease and ulcerative colitis, are to achieve clinical, endoscopic and ideally histological remission and improve the quality of life of these patients. Current therapies are effective in achieving remission in most cases, but there is a lack of clear guidelines on their optimal duration. This review aims to evaluate the current evidence on the withdrawal of therapy with 5-aminosalicylates, thiopurines and methotrexate. We also aim to identify which specific group of patients, while in remission and in the absence of risk factors, may be able to discontinue therapy without a significant risk of relapse. (C) 2019 Elsevier Espana, S.L.U. All rights reserved.

引用

页码：339 / 347

页数：9

共 96 条

[61]

MARSHALL JK, 1995, ALIMENT PHARM THERAP, V9, P293

[62] From bench to bedside: fecal calprotectin in inflammatory bowel diseases clinical setting [J].

Mumolo, Maria Gloria ;

Bertani, Lorenzo ;

Ceccarelli, Linda ;

Laino, Gabriella ;

Di Fluri, Giorgia ;

Albano, Eleonora ;

Tapete, Gherardo ;

Costa, Francesco .

WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (33) :3681-3694

[63] Effect of phenotype on health care costs in Crohn's disease: A European study using the Montreal classification [J].

Odes, Selwyn ;

Vardi, Hillel ;

Friger, Michael ;

Wolters, Frank ;

Hoie, Ole ;

Moum, Bjorn ;

Bernklev, Tomm ;

Yona, Hagit ;

Russel, Maurice ;

Munkholm, Pia ;

Langholz, Ebbe ;

Riis, Lene ;

Politi, Patrizia ;

Bondini, Paolo ;

Tsianos, Epameinondas ;

Katsanos, Kostas ;

Clofent, Juan ;

Vermeire, Severine ;

Freitas, Joao ;

Mouzas, Lannis ;

Limonard, Charles ;

O'Morain, Colm ;

Monteiro, Estela ;

Fornaciari, Giovanni ;

Vatn, Morten ;

Stockbrugger, Reinhold .

JOURNAL OF CROHNS & COLITIS, 2007, 1 (02) :87-96

[64] DOUBLE-BLIND WITHDRAWAL TRIAL OF AZATHIOPRINE AS MAINTENANCE TREATMENT FOR CROHNS-DISEASE [J].

ODONOGHUE, DP ;

DAWSON, AM ;

POWELLTUCK, J ;

BOWN, RL ;

LENNARDJONES, JE .

LANCET, 1978, 2 (8097) :955-957

[65] Methotrexate in chronic active ulcerative colitis: A double-blind, randomized, Israeli multicenter trial [J].

Oren, R ;

Arber, N ;

Odes, S ;

Moshkowitz, M ;

Keter, D ;

Pomeranz, I ;

Ron, Y ;

Reisfeld, I ;

Broide, E ;

Lavy, A ;

Fich, A ;

Eliakim, R ;

Patz, J ;

Bardan, E ;

Villa, Y ;

Gilat, T .

GASTROENTEROLOGY, 1996, 110 (05) :1416-1421

[66] Meta-analysis: factors predicting post-operative recurrence with placebo therapy in patients with Crohn's disease [J].

Pascua, M. ;

Su, C. ;

Lewis, J. D. ;

Brensinger, C. ;

Lichtenstein, G. R. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (05) :545-556

[67] Methotrexate for maintenance of remission in Crohn's disease [J].

Patel, Vishal ;

Wang, Yongjun ;

MacDonald, John K. ;

McDonald, John W. D. ;

Chande, Nilesh .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (08)

[68]

Pearson DC, 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000067

[69] Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease [J].

Peyrin-Biroulet, Laurent ;

Khosrotehrani, Kiarash ;

Carrat, Fabrice ;

Bouvier, Anne-Marie ;

Chevaux, Jean-Baptiste ;

Simon, Tabassome ;

Carbonnel, Frank ;

Colombel, Jean-Frederic ;

Dupas, Jean-Louis ;

Godeberge, Philippe ;

Hugot, Jean-Pierre ;

Lemann, Marc ;

Nahon, Stephane ;

Sabate, Jean-Marc ;

Tucat, Gilbert ;

Beaugerie, Laurent .

GASTROENTEROLOGY, 2011, 141 (05) :1621-U150

[70]

Pizarro G, 2017, REV MED CHILE, V145, P1319, DOI 10.4067/S0034-98872017001001319

← 1 2 3 4 5 6 7 8 9 10 →